Psychiatrist and Writer | Basics of Psychiatry | Future of the physical exam | Medical systems & AI.
Jul 31, 2026
•
5 min read
Where the supply chain stands, how two agents compare head-to-head, and the serendipitous path that brought a drug class to market.
Jul 24, 2026
July 23rd, 2026 newsletter
Jul 17, 2026
6 min read
Compounds nearing approval, a close look at tolerability data, and the methodology shaping psychiatric evidence.
Jul 11, 2026
CMS Medicaid frailty exemption now requires psychiatric documentation
Jul 3, 2026
Generic availability, adverse-effect profiles, and diagnostic history
Jun 26, 2026
Pipeline drugs, a head-to-head comparison, and the legal past behind it
Jun 19, 2026
What cleared regulatory review, how the agents work at a receptor level, and how psychiatric science builds its evidence base.
Jun 12, 2026
Regulatory updates, a close look at tolerability data, and the legal precedents that shaped current practice.
Jun 5, 2026
Where generic shortages stand, how to apply common rating scales at the bedside, and what shapes the evidence psychiatry relies on.
May 29, 2026
What is advancing toward approval, how the pharmacology works, and the path that brought a key compound to clinic.
May 22, 2026
New FDA approvals, antipsychotic comparisons, and diagnostic history
May 16, 2026
From supply chain gaps to receptor-level pharmacology and the courtroom decisions behind current prescribing law.
May 8, 2026
What is advancing through trials, how key rating scales perform in practice, and the origins of a modern diagnosis.
May 1, 2026
A look at what cleared approval, what the side-effect data actually show, and how a landmark compound came to exist.
Apr 26, 2026
Where supply stands on key generics, what the adverse-event data actually show, and how a diagnosis took its current shape.
Apr 17, 2026
Pipeline Drugs, Medication Comparison, HIstorical/Legal Context
Mar 17, 2026
3 min read
Welcome to the Psychopharmacology Reference Newsletter
